Capital Cell is a pan-European crowdinvesting and alternative investment platform dedicated to biotech, health and life sciences companies, letting retail and accredited investors co-invest alongside VCs and business angels in early-stage rounds (Seed to Series A/B). Founded in Barcelona in 2015 as Europe's first life-sciences-specific equity crowdfunding platform, it has channelled roughly €107-162M into 120-170 funding rounds and is CNMV-authorised to operate across the EU (France, Germany, Italy, Portugal, Netherlands, Belgium, Denmark) plus a UK arm.
SectorsFintech, Crowdfunding / Crowdinvesting, Healthtech & Bio, Biotech investment platform
Start-up MapFintech › Wealth & investing
Founders
Global models 5
OOurCrowd
Israel · www.ourcrowd.com ↗
Crowdinvesting platform where accredited investors co-invest alongside a VC in vetted early-stage rounds, with a strong health and life-sciences portfolio.
$200MComparable
RRepublic
United States · republic.com ↗
Equity crowdfunding platform letting retail and accredited investors buy into start-up rounds, often alongside venture investors.
$150MComparable
CCrowdcube
United Kingdom · www.crowdcube.com ↗
Regulated European equity crowdfunding platform that charges fees on raises and lets retail investors join seed-to-growth rounds next to VCs and angels.
$80MComparable
SSeedrs
United Kingdom · www.seedrs.com ↗
Pan-European equity crowdinvesting platform with nominee structure and a secondary market, letting retail investors co-invest in early-stage rounds.
$60MComparable
WWefunder
United States · wefunder.com ↗
Reg CF equity crowdfunding platform that earns fees on start-up raises funded by retail investors, often alongside angels and VCs.
$25MComparable
In the same niche 30 others
See all in the Start-ups Map →
Notes: Most funded first
Investors 2
J
John Bethell
SSeedBlink
Funding rounds 2
·1 not counted| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-01-23 | Seed (estimated) | €325K |
Lead not disclosed
+2 more
|
| 2018-09-25 | Seed | approximately €910K | Lead not disclosed |